Closed
SectorHealthcare
105.67 2.38
24h
Min
100.77
Max
105.77
Income | -27M 103M |
---|---|
Sales | 5.6M 628M |
P/E Sector Avg | 30.602 57.333 |
EPS | 1.69 |
Profit margin | 16.425 |
Employees | 1,800 |
EBITDA | -39M 152M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +52.66% upside |
Next Earnings | 5 maj 2025 |
---|
Market Cap | -5.1B 10B |
---|---|
Previous open | 103.29 |
Previous close | 105.67 |
By Trading Central
Confidence
Strong Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 155.32 USD 52.66%
High 190 USD
Low 96 USD
Based on 20 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$